Pulmonary tuberculosis in a BCG vaccinated area: Relationship of disease severity with immunological and hematological parameters and drug resistance patterns

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 27, Issue 2, 1996, Pages 257-262

  Hussain, Rabia ^a,b   Hasan, Rumina ^a,b   Khurshid, Mohd ^a,b   Sturm, A Willem ^a,b   Ellner, Jerrold J ^c   Dawood, Ghaffar ^d  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d Masoomeen Trust Hospital   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD; CHILD; DRUG RESISTANCE; FEMALE; HEALTH; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INFANT; LUNG TUBERCULOSIS; MALE; MICROBIOLOGY; MIDDLE AGED; PAKISTAN; POVERTY; PRESCHOOL CHILD; SEX RATIO; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BCG VACCINE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PAKISTAN; POVERTY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; TUBERCULOSIS, PULMONARY; URBAN HEALTH;

EID: 0030154301     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Aziz A, Ishaq M, Jaffer NA, et al. Clinical trial of two short-course (6 months) regimens and a standard regimen (12 months) chemotherapy in retreatment of pulmonary tuberculosis in Pakistan: results 18 months after completion of treatment (Lahore tuberculosis study). Am Rev Respir Dis 1986; 134 : 1056-61.
2. Aziz A, Siddiqui SH, Aziz K, et al. Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan. Tubercle 1989; 70 : 45-51.
3. Buttler WR, Kilburn JO. Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob Agents Chemother 1983; 24 : 600-1.
4. Cauthen G, Pio A, ten Dam HG. Annual risk of tuberculosis infection in developing countries since 1975. CDC Atlanta/WHO International Document, 1987.
5. Crofton J, Clinical features of tuberculosis. In: Seton A, Seton D, Gordon A, eds. Crofton and Douglas Respiratory Diseases. 4th ed. London: Backwell Scientific, 1990; pp 395-421.
6. Ellner JJ, Boom WH, Edmonds KL, et al. Regulation of the immune response to Mycobacterium tuberculosis. In: Ayoub EM, Cassell GH, Branche Jr WC, Henry TJ, eds. Microbial Determinants of Virulence and Host Response. Washington DC, 1990; 77-91.
7. Griffith M, Barrett HL, Bodily HL, Wood RM. Drug susceptibility test for tubercuiosis using drug impregnated disks. Am J Clin Pathol 1967; 47 : 812-7.
8. Hussain R, Dawood G, Abrar N, et al. Selective increases in antibody isotypes and IgG subclass responses to secreted antigens in tuberculosis patients and household contacts. Clin Diagn Lab Immunol 1995; 2 : 726-32.
9. Khan J, Islam N, Ajanee N, et al. Drug resistance of Mycobacterium tuberculosis in Karachi, Pakistan. Trop Doctor 1993; 23 : 13-4.
10. Reidler HL, Cauthen GM, Block AB. Tuberculosis and AIDS - Florida. Arch Intern Med 1989; 149 : 1268-73.
11. Thuer CP, Hopewell PC, Elias D, et al. Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 1990; 162 : 8-12.